INSULET CORP · Surgical & Medical Instruments & Apparatus

PODD

Low riskNext report: Around Nov 5 (est.)

View price ↗

The short version

A profitable company with growing sales. Institutions are adding.

Going well

Sales up 24% in the latest quarter vs a year ago
Profitable
Sales up 31% last year

Money moves

No insider buying or selling in the last 30 days
Institutions added 3% to their holdings in the quarter ending June 2026 (408 bought, 386 sold)
Held by Ray Dalio (Bridgewater)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$149.35+0.2% that day

Company value: $10.4B; Share price times all shares
Price vs profit (P/E): 28.0x; You pay about $28 for each $1 of yearly profit
Price vs sales: 3.4x; Company value is 3.4 times a year of sales
Cash vs value: 5%; Cash as a share of company value
Debt vs value: 0%; Debt as a share of company value

From PODD's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$801.7M+24% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $3.1B, up 29% from the 12 months before. Over 5 years, sales grew about 25% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of PODD. Starting points are the company's recent numbers.

Sales growth+29% a yearRecently: +29% a yearProfit margin12%Last 12 months: 12.3%P/E at the end28xToday: 28.0x. Many steady companies trade at 12x to 25xShare count change+1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$10.9B

Profit in 5 years$1.3B

Price these guesses point to$502.81+237% vs $149.35 todayAbout +27% a year, before dividends

What today's price needs: with a 12% margin and a 28x P/E, sales would have to grow about 1.2% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

4/7Mixed

PassReturn on equity 15%+Earns a lot on the money owners have in the business.18.1%
PassDebt under half of equityNot relying on borrowed money.0.01x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.9.1%
MissProfitable every yearSteady profits, not one good year.8 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$377.7M
MissShare count not growingNot diluting owners. Falling means buybacks.+2.8% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.71.6%

Revenue: $2.7B; +30.7% vs prior year
5-year growth: +24.5%/yr; revenue, per year
Total debt: $18.4M; 0.01x equity
Current ratio: 2.81x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.